|
|
Other links at Articles > Neurology and Neurosurgery |
| 2. |
FTY720 (Fingolimod) for Relapsing Multiple Sclerosis
|
|
|
A recent Phase II study has demonstrated that oral FTY720 is effective in reducing disease activity in relapsing multiple sclerosis with a favorable adverse-effect profile. These results are awaiting confirmation in the three ongoing Phase III clinical trials
Expert Review of Neurotherapeutics
|
|
|